Skip to content
  • Tuesday, 30 June 2026
  • 8:51 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Bayer Acquires Perfuse Therapeutics for Up to $2.45 Billion to Bolster Ophthalmology Pipeline with Novel Endothelin Receptor Antagonist
Pharmaceutical R&D

Bayer Acquires Perfuse Therapeutics for Up to $2.45 Billion to Bolster Ophthalmology Pipeline with Novel Endothelin Receptor Antagonist

Teuku Ryan May 6, 2026 0

Bayer AG is set to significantly expand its presence in the ophthalmology market with the acquisition of Perfuse Therapeutics, a…

Read More
Breakthrough Human-Only Bone Marrow Model Paves the Way for Advanced Blood Cancer Research and Reduced Animal TestingLabcorp and Children’s Hospital of Philadelphia Forge Strategic Alliance to Revolutionize Pediatric Diagnostics and National AccessScience News: Empowering Public Understanding of Science Since 1921Breakthrough in PFAS Degradation Scientists Identify Hydrogen Radicals as Key to Destroying Forever Chemicals Using UV Light
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveHigh-Dimensional Topological Structures Discovered in Entangled Photons Offer New Framework for Quantum Information StabilityWater-in-Diesel Emulsion Technology Offers Significant Emissions Reduction Potential Without Engine Modification
Glioblastoma Research Reveals Skull Erosion and Immune System Reprogramming Reshaping Treatment StrategiesPioneering Sequencing by Synthesis: David Klenerman Reflects on a Decade of Innovation and the Future of BiotechDiabetes to MASH: the specimens behind GLP-1’s widening rosterSeven Pharma Companies Selected for FDA PreCheck Pilot Program to Bolster U.S. Drug Supply Chain
YOU MAY HAVE MISSED
Stem Cell & Regenerative Medicine
Glioblastoma Research Reveals Skull Erosion and Immune System Reprogramming Reshaping Treatment Strategies
Dwi Wanna Jun 30, 2026
Biotech & Genetic Research
Pioneering Sequencing by Synthesis: David Klenerman Reflects on a Decade of Innovation and the Future of Biotech
Jia Lissa Jun 30, 2026
Laboratory Automation & Robotics
Diabetes to MASH: the specimens behind GLP-1’s widening roster
Lana Keisha Jun 30, 2026
Pharmaceutical R&D
Seven Pharma Companies Selected for FDA PreCheck Pilot Program to Bolster U.S. Drug Supply Chain
Teuku Ryan Jun 30, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ